Material from the first Phase 2 test has been sent to a leading global fumed silica manufacturer (under LOI) and to an ...

Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 2 study titled ‘A ...

Enlivex Therapeutics (($ENLV)) announced an update on their ongoing clinical study. Study Overview: Enlivex Therapeutics is conducting a Phase 2 ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Kochi Metro`s Pink Line extending to Kakkanad targets June 2026 opening for the first five stations. Construction update on ...

The Chennai Metro Rail Limited (CMRL) has begun safety certification trials on its Phase 2 network, with tests now underway ...

Kansas athletics director Travis Goff addressed the timeline for a second phase to the Memorial Stadium renovation project.

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

Viking Therapeutics' stock drops 40% despite strong Phase 2 weight-loss drug results. See here to know why I remain ultra bullish on VKTX stock.

In my view, Aficamten has great safety compared to Camzyos, which failed in its nHCM Phase 3. CYTK’s Ulacamten adds ...